Beaird Harris Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-63
Closed -$7.53K 654
2022
Q4
$7.53K Buy
+63
New +$7.53K ﹤0.01% 358